Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

Recent & Breaking News (TSXV:SBM)

Sirona Biochem Announces Resignation of Board Director

MarketWire Canada October 27, 2017

Sirona Biochem Announces Close of Oversubscribed Private Placement

MarketWire Canada October 26, 2017

Sirona Biochem Announces Financing

MarketWire Canada October 24, 2017

Sirona Biochem to Present Kel-01 at Cosmetic 360 in Paris, France

MarketWire Canada October 16, 2017

Sirona Subsidiary, TFChem, Receives Final Loan Tranche from French Public Investment Bank for Anti-Aging Project

MarketWire Canada September 27, 2017

Sirona Biochem CEO's Report on Progress

MarketWire Canada September 21, 2017

Sirona Biochem Announces Resignation of Board Director

MarketWire Canada September 13, 2017

Sirona Biochem Receives TSX Venture Exchange Approval on Warrant Extension

MarketWire Canada August 23, 2017

Sirona Biochem Announces Positive Efficacy Results for Skin Lightening Library

MarketWire Canada July 6, 2017

Sirona Biochem Closes Convertible Note Financing

MarketWire Canada June 5, 2017

Sirona Biochem Announces Convertible Note Financing

MarketWire Canada May 31, 2017

Sirona Biochem Receives TSX Venture Exchange Approval on Warrant Extension

MarketWire Canada April 20, 2017

Sirona Biochem Announces Keloid Data Accepted for Presentation to the Society of Investigative Dermatology (SID)

MarketWire Canada April 5, 2017

Sirona Biochem Announces Management Changes

MarketWire Canada February 16, 2017

Sirona Biochem Closes Convertible Note Financing

MarketWire Canada February 3, 2017

Sirona Biochem Announces Convertible Note Financing

MarketWire Canada January 31, 2017

Sirona Biochem CEO's Report on Progress

MarketWire Canada December 8, 2016

Sirona Biochem CEO to Present at French Consulate and Business in France Roundtable Event

MarketWire Canada October 25, 2016

Sirona Biochem -- Results of Annual General Meeting

MarketWire Canada September 22, 2016

Sirona Biochem Initiates Research and Development on New Therapies for Keloid Scars and Acne Vulgar

Marketwired April 18, 2016